Trial Profile

Investigation of PSMA PET/CT as an Imaging Biomarker in Solid Tumors

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 10 Jan 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Gallium (68Ga) gozetotide (Primary)
Indications Prostate cancer; Solid tumours
Focus Diagnostic use
Acronyms BASKET PSMA

Most Recent Events

08 Jan 2025 Status changed from recruiting to completed.
31 May 2023 Planned number of patients changed from 400 to 1200.
31 May 2023 Planned End Date changed from 1 Jul 2021 to 1 Jul 2023.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com